LEVEL OF SERUM PROLACTIN IN THYROID ASSOCIATED CANCER PATIENTS IN THE SUMMON AREA OF SINDH PAKISTAN
Main Article Content
Keywords
Prolactin, Thyroid disorders, Luteinizing hormone hormones, FSH, T4, T 3
Abstract
It is of interest to document the serum prolactin levels among thyroid associated cancer patients in the Summon area of Sindh Pakistan. Hence, we inspected 20 cancer-positive thyroid patients in the hailstones locales of and East Asia and assessed the linked chemical levels in the blood. Blood samples are gathered for the hormonal profile like prolactin, free T4 (FT4) luteinizing compound (LH), free T3 (FT3), follicle-stimulating hormone (FSH). Moreover, estimation of thyroid organ extent was also completed for the population. Data shows critical contrast in the degree of prolactin among the positive cases with cancer. FSH, LH, FT4 and FT3 did not show critical distinctions among cancer patients linked with thyroid problems. Thus, data shows LH, FSH, FT3, FT4, and TSH, except for prolactin did not vary essentially among male and female thyroid patients linked with cancer in this study population. However, reason growth hormone (GH) treatment in grown-ups adjusted thyroid capacity with acromegaly (a disorder with increased growth hormone secretion) showing frequent thyroid infection. This data helps in the treatment of thyroid associated cancer patients in the Summon area of Sindh Pakistan.
References
2. Popanda, O., Schattenberg, T., Phong, C. T., Butkiewicz, D., Risch, A., Edler, L., & Schmezer, P. (2004). Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis, 25(12), 2433-2441. .
3. Fallahi, P., Ferrari, S. M., Elia, G., Nasini, F., Colaci, M., Giuggioli, D. & Antonelli, A. (2016). Novel therapies for thyroid autoimmune diseases. Expert Review of Clinical Pharmacology, 9(6), 853-861.
4. Mooradian, A. D. (2019). Age-related resistance to thyroid hormone action. Drugs & aging, 36(11), 1007-1014.
5. Horrobin, D. F. (1979). Cellular basis of prolactin action: involvement of cyclic nucleotides, polyamines, prostaglandins, steroids, thyroid hormones, NaK ATPases and calcium: relevance to breast cancer and the menstrual cycle. Medical Hypotheses, 5(5), 599-620.
6. Warnet, A. (1992). The role of octreotide (Sandostatin®) in non-growth hormone-, non-thyroidstimulating hormone-, and non-prolactin-secreting adenomas. Metabolism, 41(9), 59-61.
7. Nagasawa, H. (2019). Pharmacology Division, National Cancer Center Research. Hormones in normal and abnormal human tissues. Volume 1, 115.
8. Pimentel, L., & Hansen, K. N. (2005). Thyroid disease in the emergency department: a clinical and laboratory review. The Journal of emergency medicine, 28(2), 201-209.
9. Aldinger, K. A., Schultz, P. N., Blumenschein, G. R., & Samaan, N. A. (1978). Thyroidstimulating hormone and prolactin levels in breast cancer. Archives of Internal Medicine, 138(11), 1638-1641.
10. Ishizuki, Y., Hirooka, Y., Murata, Y., & Togashi, K. (1991). The effects on the thyroid gland of soybeans administered experimentally in healthy subjects. Nihon Naibunpi Gakkai Zasshi, 67(5), 622-629.
11. American Society for Clinical Investigation. (1959). The Journal of Clinical Investigation (Vol. 38). American Society for Clinical Investigation.
12. Hadi, M. S., & Hamza, E. A. (2021). Effects of thyroid dysfunction on liver tissue in male rats. Plant Arch, 21(1), 1699-1703.
13. Hopkins, P. N., & Williams, R. R. (1981). A survey of 246 suggested coronary risk factors. Atherosclerosis, 40(1), 1-52.
14. Spencer, C. A., Takeuchi, M., & Kazarosyan, M. (1996). Current status and performance goals for serum thyrotropin (TSH) assays. Clinical chemistry, 42(1), 140-145.
15. Fraichard, A., Chassande, O., Plateroti, M., Roux, J. P., Trouillas, J., Dehay, C., ... & Samarut, J.
(1997). The T3Rα gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production. The EMBO journal, 16(14), 4412-4420.
16. Chang, L. Y., Lin, T. Y., Hsu, K. H., Huang, Y. C., Lin, K. L., Hsueh, C., ... & Lee, C. Y. (1999). Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. The Lancet, 354(9191), 1682-1686.
17. Davies, T. F., Ando, T., Lin, R. Y., Tomer, Y., & Latif, R. (2005). Thyrotropin receptor– associated diseases: from adenomata to Graves disease. The Journal of clinical investigation, 115(8), 1972-1983.
18. Mio, C., Gerratana, L., Bolis, M., Caponnetto, F., Zanello, A., Barbina, M., ... & Puglisi, F. (2019). BET proteins regulate homologous recombination‐mediated DNA repair: BRCAness and implications for cancer therapy. International journal of cancer, 144(4), 755-766.
19. Burch, H. B. (2019). Drug effects on the thyroid. New England Journal of Medicine, 381(8), 749761.
20. Narang, R., Cleland, J. G. F., Erhardt, L., Ball, S. G., Coats, A. J. S., Cowley, A. J., ... & PooleWilson, A. (1996). Mode of death in chronic heart failure: a request and proposition for more accurate classification. European heart journal, 17(9), 1390-1403.
21. Szpunar, M. J., & Parry, B. L. (2018). A systematic review of cortisol, thyroid-stimulating hormone, and prolactin in peripartum women with major depression. Archives of women's mental health, 21, 149-161.
22. Brooks, A. J., & Waters, M. J. (2010). The growth hormone receptor: mechanism of activation and clinical implications. Nature Reviews Endocrinology, 6(9), 515-525.
23. Shao, Q., Li, J., Gao, L., Guo, X., Wang, Z., Deng, K., & Xing, B. (2019). Changes in thyroid volume and thyroid function in acromegaly after surgery in Chinese population.
24. Dagdelen, S., Cinar, N., & Erbas, T. (2014). Increased thyroid cancer risk in acromegaly. Pituitary, 17, 299-306.
25. Looij, B. J., Roelfsema, F., Frölich, M., & Kruseman, A. C. N. (1991). The interaction of GHRH with TRH in acromegaly: a controlled study. European Journal of Endocrinology, 125(4), 337341.
26. Carroll, P. V., Christ the members of Growth Hormone Research Society Scientific Committee, E. R., Bengtsson, B. A., Carlsson, L., Christiansen, J. S., Clemmons, D., ... & Thorner, M. (1998). Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. The Journal of Clinical Endocrinology & Metabolism, 83(2), 382-395.
27. Jørgensen, J. O. L., Pedersen, S. A., Laurberg, P., Weeke, J., Skakkebaek, N. E., & Christiansen, J. S. (1989). Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. The Journal of Clinical Endocrinology & Metabolism, 69(6), 1127-1132.
28. Jørgensen, J. O. L., Møller, J., Laursen, T., Ørskov, H., Christiansen, J. S., & Weeke, J. (1994). Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose‐dependent manner and suppresses circadian thyrotrophin levels: studies in GH‐deficient adults. Clinical Endocrinology, 41(5), 609-614.
29. Giavoli, C., Cappiello, V., Porretti, S., Ronchi, C. L., Orsi, E., Beck-Peccoz, P., & Arosio, M. (2003). Growth hormone therapy in GH-deficient adults: Continuous vs. alternate-days treatment. Hormone and metabolic research, 35(09), 557-561.
30. Glynn, N., Kenny, H., Quisenberry, L., Halsall, D. J., Cook, P., Kyaw Tun, T., ... & Agha, A. (2017). The effect of growth hormone replacement on the thyroid axis in patients with hypopituitarism: in vivo and ex vivo studies. Clinical endocrinology, 86(5), 747-754.
31. Glynn, N., & Agha, A. (2019). The frequency and the diagnosis of pituitary dysfunction after traumatic brain injury. Pituitary, 22, 249-260.
32. Losa, M., Scavini, M., Gatti, E., Rossini, A., Madaschi, S., Formenti, I., ... & Lanzi, R. (2008). Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency. Thyroid, 18(12), 1249-1254.
33. Amato, G., Izzo, G., Salzano, I., & Bellastella, A. (1996). Recombinant human growth hormone treatment at low doses does not significantly change thyroid function in growth hormone deficient adults. Journal of endocrinological investigation, 19, 563-566.
34. Rapoport, B., Chazenbalk, G. D., Jaume, J. C., & McLachlan, S. M. (1998). The thyrotropin (TSH)-releasing hormone receptor: interaction with TSH and autoantibodies. Endocrine reviews, 19(6), 673-716.
35. MacLatchy, D. L., Kawauchi, H., & Eales, J. G. (1992). Stimulation of hepatic thyroxine 5'deiodinase activity in rainbow trout (Oncorhynchus mykiss) by Pacific salmon growth hormone. Comparative Biochemistry and physiology. Comparative Physiology, 101(4), 689-691.
36. Darras, V. M., Verhoelst, C. H., Reyns, G. E., Kühn, E. R., & Geyten, S. V. D. (2006). Thyroid hormone deiodination in birds. Thyroid, 16(1), 25-35.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Muhammad Yousif Seelro
Dr. M.A. Kazi Institute of Chemistry, University of Sindh Jamshoro, 76080, Sindh - Pakistan
Aftab Ahmed Kandhro
Dr. M.A. Kazi Institute of Chemistry, University of Sindh Jamshoro, 76080, Sindh - Pakistan
Abdul Qadeer Laghari
Mehran University of Engineering & Techonlogy Sindh - Pakistan
Khadim Ali Gishkori
Dr. M.A. Kazi Institute of Chemistry, University of Sindh Jamshoro, 76080, Sindh - Pakistan
Muhammad Younis Talpur
Dr. M.A. Kazi Institute of Chemistry, University of Sindh Jamshoro, 76080, Sindh - Pakistan
Inayatullah
Dr. M.A. Kazi Institute of Chemistry, University of Sindh Jamshoro, 76080, Sindh - Pakistan
Ahsan Ali Memon
College of Pharmacy, Liaquat University of Medical & Health Sciences, Jamshoro, -76090 - Pakistan
Sikander Munir Memon
Ph.D, Assistant Professor & Head of the Department Of Community Dentistry, LUMHS, Jamshoro - Pakistan
Maria Ahsan memon
College of Pharmacy, Liaquat University of Medical & Health Sciences, Jamshoro, -76090 - Pakistan